593 related articles for article (PubMed ID: 32059012)
21. Lower frequency of TLR9 variant associated with protection from breast cancer among African Americans.
Chandler MR; Keene KS; Tuomela JM; Forero-Torres A; Desmond R; Vuopala KS; Harris KW; Merner ND; Selander KS
PLoS One; 2017; 12(9):e0183832. PubMed ID: 28886076
[TBL] [Abstract][Full Text] [Related]
22. miRNAs as drivers of TMPRSS2-ERG negative prostate tumors in African American men.
Yates C; Long MD; Campbell MJ; Sucheston-Campbell L
Front Biosci (Landmark Ed); 2017 Jan; 22(2):212-229. PubMed ID: 27814612
[TBL] [Abstract][Full Text] [Related]
23. Androgen receptor mutations and polymorphisms in African American prostate cancer.
Koochekpour S; Buckles E; Shourideh M; Hu S; Chandra D; Zabaleta J; Attwood K
Int J Biol Sci; 2014; 10(6):643-51. PubMed ID: 24948877
[TBL] [Abstract][Full Text] [Related]
24. Racial Variations in Prostate Cancer Molecular Subtypes and Androgen Receptor Signaling Reflect Anatomic Tumor Location.
Faisal FA; Sundi D; Tosoian JJ; Choeurng V; Alshalalfa M; Ross AE; Klein E; Den R; Dicker A; Erho N; Davicioni E; Lotan TL; Schaeffer EM
Eur Urol; 2016 Jul; 70(1):14-17. PubMed ID: 26443432
[TBL] [Abstract][Full Text] [Related]
25. The Impact of Inherited Genetic Variation on DNA Methylation in Prostate Cancer and Benign Tissues of African American and European American Men.
Delgado D; Gillard M; Tong L; Demanelis K; Oliva M; Gleason KJ; Chernoff M; Chen L; Paner GP; Vander Griend D; Pierce BL
Cancer Epidemiol Biomarkers Prev; 2024 Apr; 33(4):557-566. PubMed ID: 38294689
[TBL] [Abstract][Full Text] [Related]
26. SEER and Gene Expression Data Analysis Deciphers Racial Disparity Patterns in Prostate Cancer Mortality and the Public Health Implication.
Zhang W; Dong Y; Sartor O; Flemington EK; Zhang K
Sci Rep; 2020 Apr; 10(1):6820. PubMed ID: 32321981
[TBL] [Abstract][Full Text] [Related]
27. TMPRSS2-ERG fusion impacts anterior tumor location in men with prostate cancer.
Yamoah K; Lal P; Awasthi S; Naghavi AO; Rounbehler RJ; Gerke T; Berglund AE; Pow-Sang JM; Schaeffer EM; Dhillon J; Park JY; Rebbeck TR
Prostate; 2021 Feb; 81(2):109-117. PubMed ID: 33141952
[TBL] [Abstract][Full Text] [Related]
28. Molecular basis for prostate cancer racial disparities.
Singh SK; Lillard JW; Singh R
Front Biosci (Landmark Ed); 2017 Jan; 22(3):428-450. PubMed ID: 27814623
[TBL] [Abstract][Full Text] [Related]
29. Transcriptomic profiling and genomic rearrangement landscape of Nigerian prostate cancer.
Mavura Y; Song H; Xie J; Tamayo P; Mohammed A; Lawal AT; Bello A; Ibrahim S; Faruk M; Huang FW
Prostate; 2023 Apr; 83(5):395-402. PubMed ID: 36598071
[TBL] [Abstract][Full Text] [Related]
30. A CD24-p53 axis contributes to African American prostate cancer disparities.
Liu W; Zhang Y; Wei S; Bae S; Yang WH; Smith GJ; Mohler JL; Fontham ETH; Bensen JT; Sonpavde GP; Chen GY; Liu R; Wang L
Prostate; 2020 May; 80(8):609-618. PubMed ID: 32168400
[TBL] [Abstract][Full Text] [Related]
31. Association of specific PTEN/10q haplotypes with endometrial cancer phenotypes in African-American and European American women.
Sutton J; Orloff MS; Michener C; Chiesa-Vottero A; Prayson R; Nowacki AS; Eng C
Gynecol Oncol; 2015 Aug; 138(2):434-40. PubMed ID: 26026735
[TBL] [Abstract][Full Text] [Related]
32. Results from a prostate cancer admixture mapping study in African-American men.
Bock CH; Schwartz AG; Ruterbusch JJ; Levin AM; Neslund-Dudas C; Land SJ; Wenzlaff AS; Reich D; McKeigue P; Chen W; Heath EI; Powell IJ; Kittles RA; Rybicki BA
Hum Genet; 2009 Nov; 126(5):637-42. PubMed ID: 19568772
[TBL] [Abstract][Full Text] [Related]
33. Interactions of
Lin HY; Callan CY; Fang Z; Tung HY; Park JY
Cancer Epidemiol Biomarkers Prev; 2019 Jun; 28(6):1067-1075. PubMed ID: 30914434
[TBL] [Abstract][Full Text] [Related]
34. Deciphering the Polygenic Basis of Racial Disparities in Prostate Cancer By an Integrative Analysis of Genomic and Transcriptomic Data.
Zhang W; Nicholson T; Zhang K
Cancer Prev Res (Phila); 2022 Mar; 15(3):161-171. PubMed ID: 34965922
[TBL] [Abstract][Full Text] [Related]
35. Demographic, lifestyle, and genetic determinants of circulating concentrations of 25-hydroxyvitamin D and vitamin D-binding protein in African American and European American women.
Yao S; Hong CC; Bandera EV; Zhu Q; Liu S; Cheng TD; Zirpoli G; Haddad SA; Lunetta KL; Ruiz-Narvaez EA; McCann SE; Troester MA; Rosenberg L; Palmer JR; Olshan AF; Ambrosone CB
Am J Clin Nutr; 2017 Jun; 105(6):1362-1371. PubMed ID: 28424184
[No Abstract] [Full Text] [Related]
36. TMPRSS2-ERG fusions linked to prostate cancer racial health disparities: A focus on Africa.
Blackburn J; Vecchiarelli S; Heyer EE; Patrick SM; Lyons RJ; Jaratlerdsiri W; van Zyl S; Bornman MSR; Mercer TR; Hayes VM
Prostate; 2019 Jul; 79(10):1191-1196. PubMed ID: 31090091
[TBL] [Abstract][Full Text] [Related]
37. Comparative Transcriptome Profiling Reveals Coding and Noncoding RNA Differences in NSCLC from African Americans and European Americans.
Mitchell KA; Zingone A; Toulabi L; Boeckelman J; Ryan BM
Clin Cancer Res; 2017 Dec; 23(23):7412-7425. PubMed ID: 29196495
[No Abstract] [Full Text] [Related]
38. Prostate cancer health disparities: An immuno-biological perspective.
Kumar S; Singh R; Malik S; Manne U; Mishra M
Cancer Lett; 2018 Feb; 414():153-165. PubMed ID: 29154974
[TBL] [Abstract][Full Text] [Related]
39. SPOP and CHD1 alterations in prostate cancer: Relationship with PTEN loss, tumor grade, perineural infiltration, and PSA recurrence.
Hernández-Llodrà S; Segalés L; Juanpere N; Marta Lorenzo T; Salido M; Nonell L; David López T; Rodríguez-Vida A; Bellmunt J; Fumadó L; Cecchini L; Lloreta-Trull J
Prostate; 2021 Dec; 81(16):1267-1277. PubMed ID: 34533858
[TBL] [Abstract][Full Text] [Related]
40. Metastatic prostate cancer is associated with distinct higher frequency of genetic mutations at diagnosis.
Al-Toubat M; Serrano S; Elshafei A; Koul K; Feibus AH; Balaji KC
Urol Oncol; 2023 Nov; 41(11):455.e7-455.e15. PubMed ID: 37838503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
